Results 151 to 160 of about 1,860,150 (261)

Safety and efficacy of a feed additive consisting of <i>Lactobacillus acidophilus</i>CNCM I-3231, <i>Ligilactobacillus salivarius</i>CNCM I-3233, <i>Lacticaseibacillus paracasei</i>CNCM I-4901, <i>Bifidobacterium longum</i>CNCM I-3227 and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i>CNCM I-3993 (FlorEquilibre® Chat) for cats (WAMINE SAS). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Martelli G, López-Puente S, Saarela M, Anguita M, Galobart J, Innocenti ML, Ortuño J, Sandalli S, Brozzi R.   +24 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Predicting maize hybrid performance with machine learning and a locus-specific weighted degree of dominance transformation. [PDF]

Front Plant Sci
Osatohanmwen BE, Vieira IC, Gholami M, Westhues CC, Sharifi AR, Beissinger TM.   +5 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Safety and efficacy of a feed additive consisting of l-lysine monohydrochloride produced with <i>Corynebacterium glutamicum</i>CGMCC 23982 for all animal species (Eppen Europe SAS). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Anguita M, Innocenti ML, Kolona M, Letocha P, Tarrés-Call J.   +20 more
europepmc   +1 more source

Additions Required [PDF]

Deutsches Ärzteblatt international, 2013
openaire   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Assessment of the feed additive consisting of astaxanthin (2a161j) for fish, crustaceans and ornamental fish for the renewal of its authorisation (BASF SE, DSM Nutritional Products Ltd., JYB Europe BV, NHU EUROPE GmbH). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Aquilina G, Bastos M, Brantom P, Gropp J, Woutersen R, Galobart J, Gkimprixi E, Manini P, Valeri P, Villa AN, Vettori MV, Pizzo F.   +27 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Role of Solid Additives in Morphological and Structural Optimization of Bulk Heterojunction Organic Solar Cells. [PDF]

Materials (Basel)
Khan MR, Jarząbek B, Ullah A.
europepmc   +1 more source